Author's Reply

Parfitt AM . Surgical, idiopathic and other varieties of parathyroid hormone deficient hypoparathyroidism. In: De Groot LJ Besser GM Cahill GF , eds. Endocrinology, chap 64, 2nd edn. Philadelphia; London: WB Saunders, 1989.

Editorial. Acquired vitamin D deficiency and hyperparathyroidism. Lancet 1988; i: 452.

Holick MF Adams JS . Vitamin D metabolism and biological function. In: Avioli LV Krane SM , eds. Metabolic Bone Diseases and Clinically Related Disorders. Philadelphia; London: WB Saunders, 1990: 155–95.

Raichel H Koefler MD Normal AW . The role of Vitamin D endocrine system in health and disease. N Engl J Med. 1989; 320: 980–91.

Krapf R Vetsch R Vetsch R Vetsh W Hulter HN . Chronic metabolic acidosis increases serum concentration of 1,25 dihydroxyvitamin D in humans by stimulating its production rate. J Clin Invest 1992; 90: 2456–63.

Reddy GS Jones G Kooh SW Fraser D. Inhibition of 25 hydroxyvitamin D₃-1-hydroxylase by chronic metabolic acidosis. Am J Physiol 1982; 243: E265–E271.

Ho SC Macdonald D Chan C Fan YK Chang SSG Swaminathan R. Determinants of serum 1,25 dihydroxy vitamin D concentration in health postmenopausal subjects. Clin Chim Acta 1994 (in press).

Dawson—Hughes B Harris S Dallal GE . Serum ionized calcium, as well as phosphorus and parathyroid hormone is associated with the plasma 1,25-dihydroxy vitamin D₃ concentration in normal post menopausal women. J Bone Min Res 1991; 6: 461–8.

Fraser DR , Calcium regulating hormones: Vitamin D. In: Nordin BEC , ed. Calcium in Human Biology. London: Springer Verlag, 1988: 27–41.

Lucas PA Brown CA Jones CR Woodhead JS Coles GA . Reduced 1,25(OH)₂ Vit D₃ may be responsible for the development of hyperparathyroidism in early chronic renal failure. Proc Eur Dial Trans Assoc 1985; 22: 1124–8.

Ritz E. Vitamin D metabolism in renal disease. J R Coll Phys 1992; 26: 394–9.

Llach F Massry SG . On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrin Metab 1985; 61: 601–5.

Hahn TJ . Drug induced disorders of vitamin D and mineral metabolism. Clinics Endocrin Metabl 1980; 9: 107–29.

Greenwood RH Prunty FTG Silver J. Osteomalacia after prolonged Gutethmide administration. BMJ 1973; 1: 643–5.

Collins N Maher J Cole M Baker M Callaghan N. A prospective study to evaluate the dose of vitamin D required to correct low levels of 25 hydroxyvitamin D calcium and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med 1991; 78 (No 286): 113–22.